• Partnering with Genoa
  • People-first Pharmacy Care

Guide: Combatting the effects of staffing shortages with an engaged pharmacy partner

Feb 18th, 2022

Demand for care from behavioral health clinics and providers is at an all-time high due to the ongoing pandemic, leading to staff burnout and shortages across the health care industry.

A strong integrated pharmacy partner can make a dramatic difference for your clinic and the people you serve. By bridging the gap between medication needs and clinic visits, a pharmacy partner can play a vital role on your care team by boosting medication adherence and lightening the burden for your clinical staff.

12 Questions to Ask About Your Pharmacy Partnership

Is your clinic getting the most out of your pharmacy partnership? Here are 12 questions you should be asking:  

  1. Are they an expert in behavioral health care?
  2. Do they actively build relationships with your patients and staff?
  3. Can they help with prior authorizations and payment support?
  4. Is medication synchronization a priority to relieve patients of unnecessary burden?
  5. Do they offer personalized adherence packaging for all consumers, at no additional cost?
  6. Are there various options for medication pick-up including free delivery and mailing?
  7. Can they complete refill reminder and wellness check calls?
  8. Are they able to provide your staff and patients with immunizations including flu and COVID-19?
  9. Do they support your team’s long-acting injectable administration?
  10. Are they actively monitoring for high-risk medications?
  11. Can they be an active partner in medication-assisted treatment?
  12. Do they support value-based contract measures?

Read the 12 services you should expect from your pharmacy partner, and how they can bridge any gaps left by staffing shortages.

Recent Posts


  • Behavioral Health
  • Clinical Insights
  • Treatment
Why medication-assisted treatment is essential for improving patient outcomes

1. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH. 2. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH....

  • 340B
Your questions, answered: 340B manufacturer pricing restrictions

Drug manufacturers began implementing restrictions for 340B pricing in 2020, citing alleged misuse by safety-net providers and explosive growth of the 340B Drug Pricing Program. Since then, restrictions for the...

  • Behavioral Health
  • Clinical Insights
  • Treatment
Currently available and emerging therapy options for treatment-resistant depression

Studies show that 50% of people with major depressive disorder don’t respond adequately to initial antidepressant treatment.1 Additionally, an estimated 30% of people with major depressive disorder (MDD) experience treatment-resistant...

  • Art Celebration
  • Consumer Stories
  • People-first Pharmacy Care
Genoa Art Celebration participant heals through art, helps others after losing daughter to substance use disorder

Content warning: This post discusses mental illness and substance use. Please call the Suicide and Crisis Lifeline at 988, the Substance Abuse and Mental Health Services Administration’s National Helpline at...